Abstract: Novel synthetic peptides are provided which are candidate vaccines against HIV-1 and which are useful in diagnostic application. The peptides comprise an amino acid sequence of a T-cell epitope of the gag protein of HIV-1, specifically p24E linked directly to an amino acid sequence of a B-cell epitope of the V3 loop protein of an HIV-1 isolate and containing the sequence GPGR, and/or the gp41 containing the sequence ELKDWA. Multimeric forms of the tandem synthetic peptides are provided.
Type:
Grant
Filed:
June 5, 1995
Date of Patent:
March 2, 1999
Assignee:
Connaught Laboratories Limited
Inventors:
Charles D. Y. Sia, Pele Chong, Michel H. Klein